Clinical Trial Update: Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/Phase 2 study of combining sintilimab with low-dose radiotherapy as neoadjuvant treatment for locally advanced dMMR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: West China Hospital | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING